Description: Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
Home Page: www.treace.com
TMCI Technical Analysis
203 Fort Wade Road
Ponte Vedra,
FL
32081
United States
Phone:
904 373 5940
Officers
| Name | Title |
|---|---|
| Mr. John T. Treace | CEO, Founder & Director |
| Mr. Thomas E. Timbie | Independent Director |
| Mr. Mark L. Hair CPA | Chief Financial Officer |
| Mr. Aaron Berutti | Sr. VP of Sales |
| Mr. Terry W. Lubben | Sr. VP of Operations |
| Mr. Scot Elder | Chief Legal & Compliance Officer and Corp. Sec. |
| Dr. Sean F. Scanlan Ph.D. | Sr. VP of Marketing |
| Mr. Daniel E. Owens | Chief HR Officer |
| Mr. Jaime A. Frias | Chief Bus. Devel. Officer |
| Ms. Shana Zink | Sr. VP of Clinical Affairs, Medical Education & Reimbursement |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 21.3794 |
| Price-to-Sales TTM: | 10.622 |
| IPO Date: | 2021-04-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 248 |